Skye Bioscience (SKYE) announced preliminary data from a diet-induced obesity model in mice. Skye’s CB1-inhibiting antibody, nimacimab, achieved significant dose-dependent weight loss of up to 16% ...
Hyperscale Data reports strong 2024 financial results and focuses on becoming a pure-play AI data center operator by 2025. Hyperscale Data, Inc. reported its preliminary unaudited financial results ...
EL MONTE, Calif.--(BUSINESS WIRE)-- Fulgent Genetics, Inc. (FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback